Woman claims Rihanna lipstick gave her herpes

Makeup samples are full of germs, but that didn’t stop one woman from trying a MAC Cosmetics lipstick. She’s now suing the company after contracting herpes.


When you go to the makeup counter, it’s a good bet that there are a lot of germs on those makeup samples. A woman in New York is suing MAC Cosmetics, the manufacturer of Rihanna‘s “RiRi Woo” lipstick, for reportedly contracting herpes from one of their cosmetic samples.

Starkeema Greenidge filed a lawsuit in Manhattan Supreme Court on May 7 claiming a MAC Cosmetics representative applied the contaminated lipstick directly to her lips. The suit states that the rep failed to let her know that the sample had been used on other attendees at the singer’s concert.

In the court papers, Greenidge reveals that she had inquired about the sanitation issue to the makeup artist at the brand’s pop-up shop. All of Rihanna’s shows feature the company’s makeup line, including the concert that the woman attended at the Barclay Center in Brooklyn, New York.

Amanda Bynes calls Rihanna “ugly” on Twitter >>

Greenidge broke out with a cold sore two days later and was diagnosed with herpes by her physician.

The waitress spoke to the New York Daily News about her ordeal and said, “I wasn’t able to work for two weeks. It cost me a lot of money. This is going to happen over and over again if nothing is done.”

The 28-year-old is suing for an undisclosed amount for emotional distress and lost wages from missing work.

Rihanna and Chris Brown wage Twitter war over breakup >>

MAC Cosmetics issued a statement on Thursday regarding the lawsuit.

A spokesperson told the Daily Beast, “Consumer safety is a top priority at MAC Cosmetics, and we take these matters very seriously. We are closely reviewing these claims.”

Rihanna partnered with MAC Cosmetics in February to coincide with her current Diamonds World Tour. The lipstick was inspired by the singer’s love for MAC’s signature red color, “Ruby Woo.”

Image courtesy of JLN Photography/WENN.com


Comments are closed.